Remote Ischemic Limb Preconditioning In Healthy Volunteers

Sponsor
University of Miami (Other)
Overall Status
Completed
CT.gov ID
NCT02553655
Collaborator
(none)
17
1
3
68.1
0.2

Study Details

Study Description

Brief Summary

The investigators would like to determine if remote ischemic leg preconditioning in healthy volunteers improves cerebral vasomotor reactivity as measured by breath holding and transcranial doppler vasomotor reactivity.

Condition or Disease Intervention/Treatment Phase
  • Procedure: 4x 5min Limb Preconditioning
  • Procedure: 3x 10min Limb Preconditioning
  • Procedure: 3x 10min Sham Preconditioning
N/A

Detailed Description

This study is to determine if remote ischemic leg preconditioning improves short and long term cerebral vasomotor reactivity in healthy volunteers as measured by breath holding and transcranial doppler vasomotor reactivity. Previous studies on brachial vasomotor reactivity have shown a beneficial effect of remote ischemic preconditioning. It remains uncertain if a similar beneficial effect can be reproduced with cerebral vasomotor testing. Many biological mechanisms and effector pathways triggered by preconditioning have demonstrated endothelial protection and beneficial vascular effects.

Study Design

Study Type:
Interventional
Actual Enrollment :
17 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
Does Remote Ischemic Limb Preconditioning Improve Cerebral Vasomotor Reactivity in Healthy Volunteers?
Actual Study Start Date :
Oct 1, 2015
Actual Primary Completion Date :
Jun 1, 2021
Actual Study Completion Date :
Jun 3, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 4x 5min Limb Preconditioning

Either the right or left leg of the participant(s) will be made transiently ischemic for 5 minutes following by 5 minutes of rest. This will be repeated for 4 times.

Procedure: 4x 5min Limb Preconditioning
A blood pressure cuff is placed over the upper thigh of the participant(s) and inflated to 30 millimeters of mercury (mmHg) above systolic blood pressure. The loss of pedal pulses is confirmed by palpation. The cuff remains inflated for 5min and is followed by 5 minutes of reperfusion/rest. This will be repeated 4 times.

Active Comparator: 3x 10min Limb Preconditioning

Either the right or left leg of the participant(s) will be made transiently ischemic for 10 minutes following by 5 minutes of rest. This will be repeated for 3 times.

Procedure: 3x 10min Limb Preconditioning
A blood pressure cuff is placed over the upper thigh of the participant(s) and inflated to 30 mmHg above systolic blood pressure. The loss of pedal pulses is confirmed by palpation. The cuff remains inflated for 10min and is followed by 5 minutes of reperfusion/rest. This will be repeated 3 times.

Sham Comparator: 3x 10min Sham Preconditioning

Either the right or left leg of the participant(s) will be squeezed without causing ischemia for 10 minutes following by 5 minutes of rest. This will be repeated for 3 times.

Procedure: 3x 10min Sham Preconditioning
A blood pressure cuff is placed over the upper thigh of the participant(s) and inflated to 40 mmHg, sufficient to apply pressure but not affect blood flow. The presence of pedal pulses is confirmed by palpation. The cuff remains inflated for 10min and is followed by 5 minutes of rest. This will be repeated 3 times.

Outcome Measures

Primary Outcome Measures

  1. Change in Vasomotor Reactivity to Carbon Dioxide (CO2) [Baseline to 24 hours, Baseline to 48 hours]

    Change in vasomotor reactivity to carbon dioxide (CO2) or breath holding from baseline

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy volunteers
Exclusion Criteria:
  • Presence of chronic medical conditions such as diabetes, hypertension, cardiac disease etc.

  • Any prescribed medication

  • Pregnancy [by history and last menstrual period]

  • Any leg injury that would, in the opinion of the investigator, affect preconditioning

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Miami Miami Florida United States 33136

Sponsors and Collaborators

  • University of Miami

Investigators

  • Principal Investigator: Sebastian Koch, MD, University of Miami

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sebastian Koch, Professor of Clinical Neurology, University of Miami
ClinicalTrials.gov Identifier:
NCT02553655
Other Study ID Numbers:
  • 20150648
First Posted:
Sep 17, 2015
Last Update Posted:
Sep 13, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2021